TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

people2

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

Helius Medical Technologies, Inc., (“Helius”), is a neurotech company in the medical device industry, focused on neurological wellness.

Helius’ origin stems from the early 1990s, and the pioneering work in neuroplasticity at the Tactile Communication and Neurorehabilitation Laboratory, (“TCNL”), at the University of Wisconsin-Madison. This work led to the development of the investigational Portable Neuromodulation Stimulator (PoNSTM), delivering neurostimulation via the tongue which has been shown in clinical studies to improve the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury.

Sensing the enormous implications of addressing a massive unmet medical need, Helius was formed as a joint venture between the scientists (Yuri Danilov, Mitch Tyler, and Kurt Kaczmarek) and commercialization experts (Philippe Deschamps, Jonathan Sackier, and Montel Williams).